Doctors Transplant Ear of Human Cells, Made by 3-D Printer
3DBio Therapeutics, a biotech company in Queens, said it had for the first time used 3-D printing to make a body part with a patent’s own cells. View Full New…
Corporate Profile
3DBio, headquartered in New York City (Long Island City, Queens), is a clinical-stage biotechnology company and leader in regenerative medicine using novel 3D-bioprinting and materials technologies to deliver safe, functional and personalized living tissues and organs, engineered on-demand for patients. 3DBio’s pioneering approach develops living tissue implants with structural and functional integrity with a four-part technology platform, including: novel and proprietary 3D-bioprinter (GMPrint™), bio-ink (ColVivo™), specialized cell culture system, and implantable protective shell (Overshell Technology). Today, 3DBio is breaking new ground with a clinical trial underway to treat Microtia, three additional programs nearing the clinic, and multiple life-changing treatment approaches in development. 3DBio is committed to providing healthcare professionals with safe and functional implant solutions delivering optimal patient outcomes.
Latest Updates
3DBio Therapeutics and the Microtia-Congenital Ear Deformity Institute Conduct Human Ear Reconstruction Using 3D-Bioprinted Living Tissue Implant in a First-in-Human Clinical Trial
- AuriNovo™ an investigational, 3D-bioprinted implant was created using a proprietary process leveraging the patient’s own tissue to generate an implantable ear - - Phase 1/2a clinical trial enrolling patients…
